Selected research
Industry Research
Cell-free DNA Testing Service Industry Research Report 2026
Market perspective
The global Cell-free DNA Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell-free DNA Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell-free DNA Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell-free DNA Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell-free DNA Testing Service include Natera, Revvity, CareDx, BillionToOne, Inc., ARUP Laboratories, Illumina, Yourgene Health, Oncogenomics and Roche. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell-free DNA Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell-free DNA Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell-free DNA Testing Service Market by Company
Natera
Revvity
CareDx
BillionToOne, Inc.
ARUP Laboratories
Illumina
Yourgene Health
Oncogenomics
Roche
Cell-free DNA Testing Service Segment by Type
Targeted Sequencing
Whole Genome Sequencing
Cell-free DNA Testing Service Segment by Application
Prenatal Testing
Oncology
Organ Transplant Monitoring
Others
Cell-free DNA Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell-free DNA Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell-free DNA Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell-free DNA Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell-free DNA Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Genome Sequencing
Applications
- Prenatal Testing
- Oncology
- Organ Transplant Monitoring
- Others
Companies covered
- Natera
- Revvity
- CareDx
- BillionToOne, Inc.
- ARUP Laboratories
- Illumina
- Yourgene Health
- Oncogenomics
- Roche
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell-free DNA Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Targeted Sequencing
- 2.2.3 Whole Genome Sequencing
- 2.3 Cell-free DNA Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Prenatal Testing
- 2.3.3 Oncology
- 2.3.4 Organ Transplant Monitoring
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Cell-free DNA Testing Service Breakdown Data by Type
- 3.1 Global Cell-free DNA Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Cell-free DNA Testing Service Forecasted Market Size by Type (2027-2032)
4 Cell-free DNA Testing Service Breakdown Data by Application
- 4.1 Global Cell-free DNA Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Cell-free DNA Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell-free DNA Testing Service Market Perspective (2021-2032)
- 5.2 Global Cell-free DNA Testing Service Growth Trends by Region
- 5.2.1 Global Cell-free DNA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell-free DNA Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Cell-free DNA Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Cell-free DNA Testing Service Market Dynamics
- 5.3.1 Cell-free DNA Testing Service Industry Trends
- 5.3.2 Cell-free DNA Testing Service Market Drivers
- 5.3.3 Cell-free DNA Testing Service Market Challenges
- 5.3.4 Cell-free DNA Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell-free DNA Testing Service Players by Revenue
- 6.1.1 Global Top Cell-free DNA Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Cell-free DNA Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell-free DNA Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell-free DNA Testing Service Head Office and Area Served
- 6.4 Global Cell-free DNA Testing Service Players, Product Type & Application
- 6.5 Global Cell-free DNA Testing Service Manufacturers Established Date
- 6.6 Global Cell-free DNA Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell-free DNA Testing Service Market Size (2021-2032)
- 7.2 North America Cell-free DNA Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell-free DNA Testing Service Market Size by Country (2021-2026)
- 7.4 North America Cell-free DNA Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell-free DNA Testing Service Market Size (2021-2032)
- 8.2 Europe Cell-free DNA Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell-free DNA Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Cell-free DNA Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell-free DNA Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Cell-free DNA Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell-free DNA Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell-free DNA Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell-free DNA Testing Service Market Size (2021-2032)
- 10.2 South America Cell-free DNA Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell-free DNA Testing Service Market Size by Country (2021-2026)
- 10.4 South America Cell-free DNA Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell-free DNA Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Cell-free DNA Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell-free DNA Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell-free DNA Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Natera
- 12.1.1 Natera Company Information
- 12.1.2 Natera Business Overview
- 12.1.3 Natera Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.1.4 Natera Cell-free DNA Testing Service Product Portfolio
- 12.1.5 Natera Recent Developments
- 12.2 Revvity
- 12.2.1 Revvity Company Information
- 12.2.2 Revvity Business Overview
- 12.2.3 Revvity Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.2.4 Revvity Cell-free DNA Testing Service Product Portfolio
- 12.2.5 Revvity Recent Developments
- 12.3 CareDx
- 12.3.1 CareDx Company Information
- 12.3.2 CareDx Business Overview
- 12.3.3 CareDx Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.3.4 CareDx Cell-free DNA Testing Service Product Portfolio
- 12.3.5 CareDx Recent Developments
- 12.4 BillionToOne, Inc.
- 12.4.1 BillionToOne, Inc. Company Information
- 12.4.2 BillionToOne, Inc. Business Overview
- 12.4.3 BillionToOne, Inc. Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.4.4 BillionToOne, Inc. Cell-free DNA Testing Service Product Portfolio
- 12.4.5 BillionToOne, Inc. Recent Developments
- 12.5 ARUP Laboratories
- 12.5.1 ARUP Laboratories Company Information
- 12.5.2 ARUP Laboratories Business Overview
- 12.5.3 ARUP Laboratories Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.5.4 ARUP Laboratories Cell-free DNA Testing Service Product Portfolio
- 12.5.5 ARUP Laboratories Recent Developments
- 12.6 Illumina
- 12.6.1 Illumina Company Information
- 12.6.2 Illumina Business Overview
- 12.6.3 Illumina Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.6.4 Illumina Cell-free DNA Testing Service Product Portfolio
- 12.6.5 Illumina Recent Developments
- 12.7 Yourgene Health
- 12.7.1 Yourgene Health Company Information
- 12.7.2 Yourgene Health Business Overview
- 12.7.3 Yourgene Health Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.7.4 Yourgene Health Cell-free DNA Testing Service Product Portfolio
- 12.7.5 Yourgene Health Recent Developments
- 12.8 Oncogenomics
- 12.8.1 Oncogenomics Company Information
- 12.8.2 Oncogenomics Business Overview
- 12.8.3 Oncogenomics Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.8.4 Oncogenomics Cell-free DNA Testing Service Product Portfolio
- 12.8.5 Oncogenomics Recent Developments
- 12.9 Roche
- 12.9.1 Roche Company Information
- 12.9.2 Roche Business Overview
- 12.9.3 Roche Revenue in Cell-free DNA Testing Service Business (2021-2026)
- 12.9.4 Roche Cell-free DNA Testing Service Product Portfolio
- 12.9.5 Roche Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst